Crouse, Jacob J. http://orcid.org/0000-0002-3805-2936
Park, Shin Ho
Byrne, Enda M. http://orcid.org/0000-0002-9491-7797
Mitchell, Brittany L. http://orcid.org/0000-0002-9050-1516
Scott, Jan http://orcid.org/0000-0002-7203-8601
Medland, Sarah E. http://orcid.org/0000-0003-1382-380X
Lin, Tian
Wray, Naomi R. http://orcid.org/0000-0001-7421-3357
Martin, Nicholas G. http://orcid.org/0000-0003-4069-8020
Hickie, Ian B. http://orcid.org/0000-0001-8832-9895
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (GNT2016346, 1086683, GNT2008196, 1086683, 1086683, 1086683, 1086683)
Article History
Received: 6 June 2023
Revised: 8 February 2024
Accepted: 20 February 2024
First Online: 4 April 2024
Competing interests
: Ian B. Hickie is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. He has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30 M Australian Government-funded Project Synergy (2017-20) and to lead transformation of mental health services internationally through the use of innovative technologies.